{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/69545da8cb029db7575279fc/69545e1c2305c7fb140af953?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"“Casper is the Peloton of Slumber, not the Nike of Sleep”  — Casper’s IPO. 23andMe’s transition. Primo Water’s acquisition.","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/69545da8cb029db7575279fc/de6e03391b2c5cb35de16a094ab0dd05.jpeg?height=200","description":"We slept on the Casper IPO documents released over the weekend, then realized they spent $80M just dealing with mattress returns last year. 23andMe hits a new corporate milestone — treating diseases with your saliva. And Primo Water boasts that it’s a pure-play water company, but it just got swallowed up.\nLearn more about your ad choices. Visit podcastchoices.com/adchoices","author_name":"Nick & Jack Studios"}